Feline calicivirus (FCV) is 1 of the most common causes of upper respiratory tract disease in cats. Other disease syndromes associated with FCV infection have been reported. Recently, calicivirus infection associated with a hemorrhagic-like disease leading to significant mortality in cats has been reported. The clinical signs are similar to those observed with the calicivirus of rabbit hemorrhagic disease. This study characterized 2 FCV isolates associated with hemorrhagic-like disease. Nucleotide sequencing of the complete genome has been done for these 2 isolates as well as for 4 additional isolates representing other disease syndromes. Previously reported sequence data for the entire genome of classical FCV (6 isolates) and a portion of the capsid gene for hemorrhagic-like FCV (3 isolates), isolated in different regions of United States were used in the genetic analysis. Sequence data were used to determine relationships among the isolates and any correlation with phenotype. Nucleotide sequence comparisons of the entire genome and individual open reading frames revealed high homology among all isolates. Data suggest that the virulence may have genetic determinants on the basis of phylogenetic clustering of the isolates associated with hemorrhagic-like disease.
Introduction
Feline calicivirus (FCV) is a significant pathogen of cats, producing a wide range of clinical diseases, the most important of which is acute upper respiratory tract disease. 7 Clinical signs associated with infection include ocular discharge, nasal discharge, lingual ulcers, 27 chronic gingivitis, pharyngitis, 38 chronic stomatitis, 37 and pneumonia. 27 Other disease manifestations have been reported and include acute arthritis, 7, 25 jaundice, and death from in utero FCV infection. 10 Existence of a carrier state is not uncommon. 41, 42 Recently, a virulent calicivirus-associated systemic hemorrhagic disease with significant mortality has occurred in cat populations in the United States. 18, 24, 30 This disease is similar to rabbit hemorrhagic disease caused by a calicivirus (genus Lagovirus, family Caliciviridae). 23 Feline calicivirus, a member of the Caliciviridae family, is a nonenveloped, single-stranded, positive-sense RNA virus. The FCV genome is composed of a single polyadenylated molecule of 7678-7693 nucleotides. The genome encodes 3 open reading frames (ORFs). The ORF1 (nucleotides 20-5305) encodes a large polyprotein, which undergoes cotranslational cleavage yielding 6 nonstructural proteins ranging in size from 5.6 to 75.6 kD. 4, 33, 36, 43 The ORF2 (nucleotide 5314 to 7317-7326) encodes the precursor of the major structural capsid protein, 5, 22 which later undergoes cleavage by a viral-encoded proteinase to a 65-66-kD mature protein. 35 The capsid protein is divided into 6 areas on the basis of genetic variability, designated A, B, C, D, E, and F representing amino acids residues 1-120, 121-396, 397-401, 402-425, 426-520, and 521-668, respectively. Area E, identified as a hypervariable region of the capsid protein, is probably responsible for the FCV antigenic variations. 1, 11, 13, 32 It contains at least 1 neutralizing epitope. 12, 40 The ORF3, which overlaps ORF2, (nucleotides 7617-7626 to 7634-7643), encodes a minor structural protein, VP2, with an unknown function. 15, 22, 34 Virus-neutralization tests indicate that FCV isolates are closely related to one another and comprise 1 serotype. Viruses recovered from cats with different clinical signs or from disparate geographic regions are genetically similar. 11, 19, 26 Genetic studies on the FCV capsid protein also suggest that only 1 genotype of FCV exists. 1, 11, 13, 16 However, some data suggest antigenic clustering of the isolates producing similar clinical signs. 9, 20 The nucleotide homology of the complete genome of different isolates ranges between 79.4% and 80%. 39 The sequence analysis of ORF1 suggests that some variable areas exist within this region. 13 The nucleotide homology of the capsid gene among FCV isolates ranges from 77.1% to 81%, whereas the amino acid similarities are 88-91%. However, the nucleotide homology is only 55-75% when the hypervariable areas (E) are compared. 5, 13, 14, 31, 32, 39 The nucleotide homology 18, 24, 30 In this study, the complete genome sequence of 6 FCV isolates was determined: 2 hemorrhagic diseaseassociated FCV isolates and 4 isolates representing other clinical diseases. The sequence data were used to determine the genetic relationship of the hemorrhagic disease-associated isolates with one another and with the other FCV isolates (including FCV sequence data obtained from GenBank). Genetic analysis, including the phylogenetic relationship among the isolates, using each region of the genome (ORF1, proteins 1 through 6, ORF2 [capsid protein], and ORF3) was done. Virus neutralization was done with serum samples obtained from the animals infected with the hemorrhagic disease-associated FCV to determine the antigenic relationship with one another and with other classical FCV isolates.
Material and methods
Viruses. Six FCV isolates were used. Five had been isolated at the Clinical Virology Laboratory, College of Veterinary Medicine, University of Tennessee, over the last 10 yr. Two of the isolates (designated UTCVM-H1 and UTCVM-H2) had been associated with hemorrhagic disease, 3 (designated UTCVM-NH1, UTCVM-NH2, and UTCVM-NH3) had been associated with classical signs of FCV, and the last isolate, also associated with classical signs of disease, was obtained from the United States Department of Agriculture (USDA). a The UTCVM-H1 isolate was identified as one associated with hemorrhagic disease on the basis of the clinical signs and necropsy. These clinical signs included pneumonia and vasculitis, with 3 deaths. The virus was easily transmitted and rapidly spread to other cats in the facility. Affected cats had high fever, depression, anorexia, jaundice, and necrotic lesions of the pinnae. Blood work evidenced thrombocytopenia, bilirubinemia, leukopenia to leukocytosis, and elevated liver enzymes. Necropsy was done on 2 cats. The lungs were markedly hemorrhagic with serosanguinous fluid on section, microvascular thrombosis, marked endothelial hyperplasia, intra-alveolar hemorrhage with fibrin, marked vascular congestion, and mild to moderate, diffuse pulmonary edema was observed. Kidneys had hemorrhage at corticomedullary junction. Pinnae had subepidermal vesicle formation and mild, multifocal microvascular thrombosis. The UTCVM-H2 isolate was identified as one associated with hemorrhagic disease primarily on the basis of clinical signs, which included lameness, swollen, edematous limbs and joints, ventral abdominal edema, anorexia, fever, and oral ulcer. Laboratory tests supported the diagnosis and ruled out other etiologies (including feline immunodeficiency virus (FIV), feline leukemia virus (FeLV), Ehrlichia canis, E. chaffeensis, Rickettsia rickettsii, aerobic and anaerobic bacteria from blood, and Blastomyces dermatitidis). The ''hemorrhagic'' FCV isolates were obtained from lung (UTCVM-H1) and oral swab (UTCVM-H2). Table 1 shows date of the isolation, the geographical location of the case(s), and a brief about clinical presentation for each FCV-disease occurrence. Genome sequence data of 6 other FCV isolates were obtained from the GenBank (names and accession numbers given in Table 3 ) and used for genetic analysis. Partial sequence data (180-210 nucleotides) of 3 FCV isolates associated with hemorrhagic disease in cats were obtained from published articles (FCV-Ari, 24 FCV-cat 15, 30 FCV-kaos 18 ).
Serum samples. Five serum samples from cats naturally infected with the UTCVM-H1, a serum sample from the cat infected with UTCVM-H2, and a negative-control serum (obtained from Liberty Research b ) were used in this study.
Virus propagation. Crandell-Reese feline kidney (CRFK) cells were used for virus isolation and virus-neutralization assays. The CRFK cells were grown in Dulbecco modified Eagle medium (DMEM) c supplemented with 5% heat-inactivated fetal bovine serum, d with standard concentrations of penicillin, streptomycin, and amphotericin B. c After sample preparation (given in Table 1 ), confluent monolayers of CRFK cells, grown in 75-cm 2 flask, were inoculated and observed daily for cytopathic effect (CPE). The viruses were grown until 50-70% CPE developed, and the cells were collected for RNA extraction.
The RNA extraction. The RNA was extracted with Trizol LS reagent, e according to the manufacturer's protocol. In brief, the infected cells were collected from the 75-cm 2 flask and pelleted by low-speed centrifugation (1,000 ϫ g). The cell pellet was resuspended in 750 l Trizol reagent and incubated for 5 min at room temperature. Two-hundred microliters of chloroform was added to the suspension, incu- 5Ј-GTGTATGAGTAAGGGTCAACC-3Ј Primer 7
5Ј-GATGAACTACCCGCCAATCA-3Ј Primer 8
5Ј-ACATCAGTGACTGATCCAAT-3Ј Primer 9
5Ј-TAACTRGCACAAGAAGGR(AϩG)CA-3Ј Primer 10 5Ј-TGAGTCGATGACTCTAGCTTTTTTTTTTTTTTTTTT-3Ј Primer 11
5Ј-TGAGTCGATGACTCTAGC-3Ј Primer 12
5Ј-CTGCCTCCTACATGGGAAT-3Ј bated for 2-3 min at room temperature, and then centrifuged at 12,000 ϫ g for 15 min at 4ЊC. The RNA, the aqueous upper phase, was precipitated by adding 500 l of isopropyl alcohol; the mixture was incubated for 10 min at room temperature and then centrifuged at 12,000 ϫ g for another 10 min at 4ЊC. The pellet obtained after centrifugation was washed with 1 ml of 75% ethyl alcohol and centrifuged at 7,500 ϫ g for 5 min at 4ЊC to obtain the RNA pellet. The RNA pellet was air dried and dissolved in 100 l of RNAsefree water. Primer design. For reverse transcriptase-polymerase chain reaction (RT-PCR), the FCV genome was divided arbitrarily into 3 major and 3 minor segments ( Fig. 1 ). Two primers (5 and 6) have been used before. 1 Various primer pairs used for RT-PCR amplification ( Table 2) were based on published sequences. Additional sequencing primers were derived from the generated sequence data.
The complementary DNA synthesis. Synthesis of complementary (cDNA) was done using Moloney-Murine Leukemia virus reverse transcriptase (M-MLV RT) Reverse Transcriptase (RTase), e according to the manufacturer's protocol. In brief, 1 l of the antisense primer ( Fig. 1 ) (50-m), 4 l of a 10 mM deoxynucleoside triphosphate (dNTP) mix, and 1-4 ng of total RNA were mixed and made up to 12 l with RNAse-free water. The mixture then was heated to 65ЊC for 5 min and quick chilled on ice. After this, 4 l of 5ϫ first-strand buffer, 2 l of 0.1 M: dithiothreitol (DTT), and 1 l of RnaseOUT recombinant ribonuclease inhibitor (40 U) e were added and the mixture incubated at 37ЊC for 2 min. Thereafter, 1 l (200 U) of M-MLV RTase was added, the mixture was incubated for 50 min at 37ЊC, and heated at 70ЊC for 15 min to inactivate the enzymes.
Polymerase chain reaction. According to the manufacturer's protocol, f 10 l of 10ϫ Ex Taq buffer, 8 l of dNTP mixture (2.5 mM each), 1 l of the sense primer (50 M), 1 l of the antisense primer (50 M), 0.5 l TaKaRa Ex Taq (5 U/l), and 4 l of the cDNA were combined and made up to 100 l with Rnase-free water. The mixture was reacted in a thermal cycler g with the following parameters: denaturation at 95ЊC for 1.5 min; 30 three-step cycles consisting of annealing at 58ЊC for 30 sec, extension at 72ЊC for 1 min, and denaturation at 95ЊC for 1 min; hold for 2 min at 50ЊC followed by 5 min at 72ЊC.
Genetic sequencing. The RT-PCR products were electrophoresed in 1% agarose h gel in 1ϫ Tris-Borate-EDTA (TBE) buffer. The band representing the target size was purified from the gel using MinElute Gel Extraction kit, following the manufacturer's protocol i in a microcentrifuge. Sequencing of the purified polymerase chain reaction (PCR) products was done at the Molecular Biology Resources Service (University of Tennessee, Knoxville, TN). j Rapid amplification of cDNA ends. The 3Ј and 5Ј ends of the FCV genome were determined using the rapid amplification of cDNA ends (RACE) system kit following the manufacturer's protocol. f The 20 nucleotides at the 5Ј end were detected using primer 9 as antisense primer for cDNA synthesis as well as for PCR ( Table 2 ). The RACE system used for the 3Ј end was designed using primer 10 for cDNA synthesis ( Table 2 ). The PCR was done using primers 11 and 12, targeting about 437-446 bases of the genome, representing nucleotides 7244-7681 (Table 2) .
Sequence analysis. Determination of ORFs, amino acid sequence, and alignment was done using the Wisconsin GCG package. k Phylogenetic tree construction was performed using distances (neighbor-joining) and growtree programs available in the Wisconsin GCG package. k Distances were done using Kimura protein distances for amino acid trees ( Fig. 4C ) and Jukes-Cantor distance for nucleotide trees (Fig. 4A, 4B ), whereas growtree was done using neighbor-joining. Virus-neutralizing antibody assay. Serum samples were tested against 4 of the 6 FCV strains used in this study (UTCVM-H1, UTCVM-H2, UTCVM-NH1, and USDA), as described previously. 8 In brief, the serum samples were heated at 56ЊC for 30 min. Two-fold serial dilutions of serum were done in disposable sterile test tubes using DMEM supplemented with 5% fetal bovine serum, starting from dilution 1:5 to 1:2,560 and transferring 25 l of each into 96-well microtiter plates. Then 200 tissue culture infective dose (TDID 50 ) of the FCV isolate in 25 l medium was added to each well. The reaction was incubated at 37ЊC for 45 min. Fifty microliters of the cell suspension containing 2 ϫ 10 5 cells/ml was added to each well after incubation. These procedures were done in duplicates. The back titration was done for each isolate along with the serum samples to verify the virus titer. The plates were incubated for 3 days at 37ЊC and examined under an inverted microscope for typical FCV CPE. The reciprocal of the highest serum dilution without detectable CPE was read as the endpoint.
Results
Sequence analysis. The nucleotide sequences and deduced amino acid sequences of isolates, UTCVM-NH1, UTCVM-NH2, UTCVM-NH3, UTCVM-H1, UTCVM-H2, and USDA, were determined and compared (GenBank information in Table 3 ). The first 56 nucleotides of the genome were conserved in all FCV isolates except UTCVM-H1, which differed in nucleotides 51 and 52, resulting in a hydrophilic amino acid (asparagine) replacing a neutral amino acid (threonine). The 5Ј untranslated region consisted of 19 nucleotides and was completely conserved among all isolates. All the FCV isolate genomes contained 3 potential ORFs. The length of ORF1 was constant in most isolates (5308 nucleotides encoding 1763 amino acids). Two exceptions were UTCVM-H2, which did not contain 3 nucleotides (nucleotides 2928-2930), and CFI/68 isolate, which did not contain 3 nucleotides (nucleotides 1802-1804) as compared with other FCV isolates. The polyprotein encoded by ORF1 is cleaved into 6 proteins: p5.6, p32, p39 (nucleoside triphosphate [NTPase]), p30, p13 (VPg), and p76 (proteinase-polymerase), respectively. 33 The cleavage sites among isolates were conserved except for an insignificant change in some isolates at amino acid residue 686, which is the cleavage site between P39 (NTPase) and P30; aspartic acid was present in UTCVM-NH2, UTCVM-NH3, UTCVM-H1, and UTCVM-H2, whereas glutamic acid was present in UTCVM-NH1 and USDA isolates.
The ORF2 encodes the capsid protein and was predicted to have 668 amino acids in all isolates except UTCVM-NH2, which had 3 more amino acids in the hypervariable area E compared with the other isolates. The start codon for ORF3 overlaps the stop codon of ORF2 and encodes 106 amino acids representing the VP2 structural protein. The number of nucleotides in the 3Ј untranslated region was variable, ranging from 44 nucleotides (USDA, UTCVM-H2, and UTCVM-NH2) to 46 nucleotides in UTCVM-NH1, 48 nucleotides in UTCVM-H1, and 52 in UTCVM-NH3.
Comparison of the entire genome sequence among isolates indicated 78.3-80.6% homology ( Fig. 2 ). The ORF3 nucleotide homology among isolates was 82.4-90.3% (data not shown). The similarities of the deduced amino acids ranged from 90.3% to 95.9% for ORF1, 88.3-94.3% for ORF2, and 95.3-100% for the ORF3 among the isolates examined (data not shown). The amino acid sequences of the hypervariable area E for the FCV isolates used in this study are given in Fig. 3 . The genetic analysis of the isolates revealed that there is very high homology of UTCVM-NH2 to vaccinal strain F9 and of FCV2024 to USDA FCV, suggesting that both cases represent the same virus with very few point mutations.
Phylogenetic analysis. The phylogenetic tree based on the complete genome nucleotide sequence revealed that all FCV isolates belong to the same genotype regardless of geographical origin or clinical signs (Fig.  4A ). The analysis also revealed that isolates F9 and UTCVM-NH2 segregate together as a result of a few point mutations. Similarly, FCV2024 and USDA also segregate together. The UTCVM-H2 and CFI/68 isolates grouped together as a result of a 3-nucleotide deletion in the ORF1, which is considered a conserved area. The phylogenetic tree based on the nucleotide sequence of the capsid protein gene (Fig. 4B ) also sug-gested that these FCV isolates belong to the same genotype. The latter tree also segregates F9 and UTCVM-NH2 isolates together, suggesting that both isolates represent the same virus (both have 9 nucleotide insertions in the E region of the capsid gene). Phylogenetic trees based on nucleotide sequences of other parts of the genome representing different proteins of ORF1 are similar to those using the complete genome and capsid protein gene (data not shown). Furthermore, phylogenetic trees based on the amino acid sequence for each of the 3 ORFs support the conclusion that FCV isolates belong to a single genotype. The 2 isolates associated with hemorrhagic disease could not be distinguished by phylogenetic analysis of the complete genome, ORF1 (using the 6 different cleaved proteins), ORF2, and ORF3 using both nucleotide and deduced amino acid sequences. Sequence data was not available for the entire genome of the FCV hemorrhagic-like disease isolates other than UTCVM-H1 and UTCVM-H2, but nucleotide sequences of a portion of the capsid E area of 3 previously isolated FCV isolates associated with the syndrome were used to create the phylogenetic tree of the hypervariable E area (data not shown). Using hypervariable E area to create a phylogenetic tree revealed 1 genotype of FCV (data not shown); however, a phylogenetic tree created using deduced amino acid residues 426-445 of the capsid protein gene showed clustering of UTCVM-H1 and UTCVM-H2 along with the hemorrhagic-like isolate Kaos (Fig. 4C) . Neutralization pattern. Seven serum samples were used to determine the neutralization pattern against 4 of the FCV isolates (UTCVM-H1, UTCVM-H2, UTCVM-NH1, and USDA). Five samples were from cats in the outbreak from which UTCVM-H1 was isolated. These 5 sera had very high antibody titers against the homologous isolate (UTCVM-H1), but they had low or no titer against other isolates. A sample from a cat infected with UTCVM-H2 had the highest antibody titer against homologous isolate (UTCVM-H2) but did have cross-reactivity with UTCVM-H1 at lower titer. The antibody titers for each sample against the 4 FCV isolates used are shown in Table 5 .
Discussion
Calicivirus infections associated with a hemorrhagic disease with significant mortality have occurred in cat populations. 18, 24, 30 FCV has been isolated from cats with fatal systemic infections and lesions attributable to vasculitis and severe necrotizing pneumonia. This novel presentation is similar to that observed with calicivirus infection of rabbit hemorrhagic disease and may represent an alteration in calicivirus tissue tropism in cats. Severe upper respiratory tract infection was also present in all reported outbreaks of the severe disease. Perhaps, FCV mutants with enhanced virulence might develop in cats infected with the classical FCV.
Virus-neutralization assays were done to determine the relationship of FCV isolates associated with hemorrhagic-like disease to one another and to other FCV isolates associated with classical disease. Not surprisingly, the pattern of neutralization revealed that the homologous virus induced the highest neutralizing antibody titer ( Table 5 ) in agreement with previous reports. 24, 30 Serum antibodies from cats infected with 2 hemorrhagic isolates (UTCVM-H1 and UTCVM-H2) had some cross-neutralizing activity, but they had low or no neutralizing antibody titers against the other FCV isolates tested. This suggests that these 2 virulent isolates share a degree of homology at the neutralizing epitope level but are distinct from the other isolates.
In this study, the complete genome of 2 FCV isolates associated with hemorrhagic-like diseases and 4 ''classical'' isolates were sequenced to determine the genetic diversity and to identify possible mutations in FCV isolates that may be correlated with disease manifestations. Also, sequence data for 6 additional isolates from GenBank were included. The nucleotide homology of the complete genome among various isolates (with 2 exceptions) was constant at about 80%, suggesting a randomly heterogeneous population of viruses, which is in agreement with the previous studies. 13, 39 Two vaccine viruses (F9 and FCV2024) appeared to be identical to disease-associated field isolates (UTCVM-NH2 and USDA, respectively).
The ORF1 encodes a polyprotein, which is cleaved by a virus-encoded proteinase. The amino acid sequences at the cleavage sites of ORF1, proposed by recent studies, 33, 36 were conserved among FCV isolates included in this study. These findings suggest that all individual proteins are produced by every FCV isolate including the FCV isolates associated with hemorrhagic disease. The latter conclusion is supported by a phylogenetic tree for each of the 6 proteins encoded by ORF1, showing that FCV isolates used in this study belong to the same genotype. Phylogenetic analysis using nucleotide and amino acid sequences of each of these 6 ORF1 proteins from the various isolates did not segregate the virulent isolates together.
Nucleotide sequences of the capsid protein gene of the various viruses had an overall homology of 74.8-81.1% (Table 4) , which reflects the variability of the capsid protein gene of the FCV isolates. The capsid protein gene is divided into 6 areas of variability, previously identified as A, B, C, D, E, and F. 32 The analysis of FCV isolates used in this study confirmed the existence of the same pattern (data not shown). The ORF3 encodes VP2 of unknown function. 15, 34 Its function, however, does not appear to be related to viral pathogenicity as suggested by the high amino acid similarities of the VP2 (95.3-100%) among different FCV isolates producing a wide range of clinical diseases.
Vaccination against FCV is a common practice. The F9 strain has been widely used for preparation of killed and attenuated vaccines. The vaccine is effective at preventing disease, but occasionally, FCV can be isolated from vaccinated cats that develop disease. 6, 8 The nature and origin of FCV isolates causing disease in vaccinated cats have not been identified. 8 Recent sequence studies of FCV isolates causing disease in vaccinated cats suggest these viruses are derived from a vaccine virus, on the basis of very high nucleotide homology of the E hypervariable region (98-100% homology) with vaccine viruses. 16, 28 The results in this study support this conclusion. The UTCVM-NH2 had 94.2% nucleotide homology (92.9% similarities comparing the amino acids) in the E region compared with the F9 isolate. The nucleotide homology between the same virus pair was 97.7% in the whole capsid protein gene. The E region may be responsible for inducing isolate-specific neutralizing antibodies and therefore may contain the immunologically relevant part of the capsid protein. 40 Five of 7 amino acid differences in the capsid protein, between F9 and UTCVM-H2, occurred in E region (amino acid residues 426-520) and 2 of 5 in amino acid residues 440-443 of the predicted E-region peptide. The latter region may be responsible for change in viral pathogenicity because those differences occur in the putative neutralizing (and perhaps attachment) site. A recent study identified neutralizing antibodies that target amino acid residues 426-460 of the capsid protein. 40 Immunity induced by the F9 vaccine may not protect against UTCVM-NH2 because of the differences in the predicted amino acids (residue 441-443), which may be a factor in the pathogenesis of FCV disease.
The amino acid residues 435-444 of various classical FCV capsid proteins were compared to the same residues of FCV associated with hemorrhagic-like disease. The 2 hemorrhagic isolates (UTCVM-H1 and UTCVM-H2), along with Kaos isolate, have a similar point mutation replacing the amino acid asparagine with serine in position 443 of the capsid protein. More interestingly, UTCVM-H1 and UTCVM-H2 have the same sequence of amino acids at position 441-443 (NNS), which is a unique sequence found only in these 2 isolates. This mutation leads to an additional glycosylation site as compared with FCV isolates associated with classical disease (data not shown). The amino acid area unique to UTCVM-H1 and UTCVM-H2 was followed by 2 amino acid residues conserved among all FCV isolates investigated, which suggests that this epitope has a role in virus neutralization and perhaps cell attachment and tropism changes. This hypothesis is in agreement with observations in a previous study, which revealed that 2 closely related FCV isolates, on the basis of amino acid sequence of residues 439-441, had the highest cross neutralization titers. 31 In this study, a phylogenetic tree based on 20 amino acids (426-445) segregated the 3 FCV isolates associated with hemorrhagic-like disease (UTCVM-H1 and UTCVM-H2 and Kaos) in a separate clade when all viruses were compared (Fig. 4C) . The latter tree also segregated F9 and CFI/68 isolates in a sep-arate clade. This is in agreement with a previous report in which monoclonal antibodies produced against amino acid residues 422-448 of the F9 isolate capsid protein cross-reacted with CFI/68 FCV isolate. 21 In addition to the extra glycosylation site for UTCVM-H1 and UTCVM-H2 found in the hypervariable area E, other FCV isolates associated with hemorrhagic disease, including FCV-Ari and FCV cat 15 have an additional glycosylation site (but in a different location). This is in disagreement with a previous report in which only 1 glycosylation site was proposed in FCV isolates; however, this work was done using only classical FCV isolates. 31 Changes of viral pathogenesis due to genomic mutation have been reported. Bovine viral diarrhea virus, an RNA virus, has insertional mutations in specific sites of the viral RNA. This is a consequence of genetic recombination of bovine cellular RNA and viral RNA or by homologous recombination within viral RNA itself. These mutations are the basis of severe disease (mucosal disease) developing in persistently infected animals. The recombinant virus is antigenically identical to the parent virus but the biotype changes (noncytopathic to cytopathic). 2 Another example of a pathogenicity change because of genetic mutation is the porcine coronavirus associated with respiratory disease, which likely originated from transmissible gastroenteritis virus (TGEV). A large deletion in the 5Ј-region of the TGEV spike glycoprotein gene may have been responsible for a change in tissue tropism from gastrointestinal tract to respiratory epithelium. 29 The viral changes producing an altered pathogenesis may be minor, even point mutations. 3 Canine parvovirus and feline panleukopenia virus have over 98% DNA homology but differ in antigenic and hemagglutination properties, and each has a distinct host range. The differences have been attributed to some amino acid differences of the capsid protein (VP1 and VP2 proteins). 3, 17 After an infection with FCV, the mutation responsible for viral pathogenicity may be occurring in the E region and more specifically in residues 435-445. Further work is therefore required to determine whether the 20-amino acid stretch within the E region of FCV may relate to virus neutralization and virus virulence.
In conclusion, nucleotide homology and predicted amino acid sequence similarities between the 2 hemorrhagic isolates, either when the complete genome or individual ORFs were compared, were no greater than when either virus was compared with any other strain of FCV. This suggests that each FCV isolate has a distinct and unique origin. However, clustering of the hemorrhagic isolates observed with residues 426-445 suggests that disease phenotype may have a genetic basis.
